Skip to content

CLLS

Cellectis SA

NASDAQ · Healthcare · Biotechnology · FR

$1.53
+4.79%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 13, 2026
EPS estimate
-$0.19
Revenue estimate
$15.2M

Latest reported

Last report date
Aug 6, 2026
EPS actual
-$0.22
EPS estimate
-$0.26
Revenue actual
$6.9M
Revenue estimate
$11.0M

Track record

Trailing twelve quarters

EPS beats (12Q)
6
EPS misses (12Q)
6
EPS in line (12Q)
0
Avg surprise (4Q)
+32.2%
Revenue beats (12Q)
2

Analyst ratings

Sell-side consensus

Consensus
Hold
Price target
$4.10
PT range
$1.30 – $8.00
Analysts
4
1 Buy2 Hold1 Sell
Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 6, 2026-$0.26-$0.22Beat 16.35%$6.9M
May 11, 2026-$0.26-$0.18Beat 30.32%$7.5M
Mar 20, 2026-$0.20-$0.26Miss -27.87%$12.2M
Nov 7, 2025-$0.10$0.01Beat 110.00%$35.2M
Mar 13, 2025$0.06-$0.16Miss -366.67%$12.7M
Mar 13, 2024-$0.22-$0.70Miss -218.18%$283.0K
Aug 3, 2023-$0.38-$0.14Beat 63.16%$178.0K
May 4, 2023-$0.30-$0.58Miss -93.33%$139.0K
Mar 8, 2023-$0.75-$0.57Beat 24.00%$16.0M
Nov 3, 2022-$0.58-$0.63Miss -8.62%
Aug 4, 2022-$0.73-$0.42Beat 42.47%$1.3M
May 12, 2022-$0.62-$0.70Miss -12.90%$1.7M

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 13, 2026